{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:25:17Z","timestamp":1793679917119,"version":"4.5.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hong Zhang","award":["82174023"],"award-info":[{"award-number":["82174023"]}]},{"name":"Hong Zhang","award":["82174023"],"award-info":[{"award-number":["82174023"]}]},{"name":"Hong Zhang","award":["82174023"],"award-info":[{"award-number":["82174023"]}]},{"name":"Hong Zhang","award":["82174023"],"award-info":[{"award-number":["82174023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01152-8","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T12:02:28Z","timestamp":1692792148000},"page":"4413-4427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["CXCL6: A potential therapeutic target for inflammation and cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Chun-Lan","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6191-0046","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"1152_CR1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1189\/jlb.0407206","volume":"826","author":"J Vandercappellen","year":"2007","unstructured":"Vandercappellen J, Noppen S, Verbeke H, et al. Stimulation of angiostatic platelet factor-4 variant (CXCL4L1\/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6\/GCP-2) in normal and tumoral mesenchymal cells. J Leukoc Biol. 2007;826:1519\u201330.","journal-title":"J Leukoc Biol"},{"key":"1152_CR2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.28487","volume":"636","author":"MS Matter","year":"2016","unstructured":"Matter MS, Marquardt JU, Andersen JB, et al. Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype. Hepatology. 2016;636:1888\u201399.","journal-title":"Hepatology"},{"key":"1152_CR3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"4206917","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;4206917:860\u20137.","journal-title":"Nature"},{"key":"1152_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/457036b","volume":"4577225","author":"A Mantovani","year":"2009","unstructured":"Mantovani A. Cancer: Inflaming metastasis. Nature. 2009;4577225:36\u20137.","journal-title":"Nature"},{"key":"1152_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.LAB.0000048719.53282.00","volume":"831","author":"A Wuyts","year":"2003","unstructured":"Wuyts A, Struyf S, Gijsbers K, et al. The CXC chemokine GCP-2\/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8\/CXCL8. Lab Invest. 2003;831:23\u201334.","journal-title":"Lab Invest"},{"key":"1152_CR6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.113.01954","volume":"626","author":"AE Norlander","year":"2013","unstructured":"Norlander AE, Saleh MA, Madhur MS. CXCL16: a chemokine-causing chronic kidney disease. Hypertension. 2013;626:1008\u201310.","journal-title":"Hypertension"},{"key":"1152_CR7","first-page":"909","volume":"903","author":"B.","year":"1997","unstructured":"B. J Rollins Chemokines Blood. 1997;903:909\u201328.","journal-title":"J Rollins Chemokines Blood"},{"key":"1152_CR8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/nm1196-1174","volume":"211","author":"BA Premack","year":"1996","unstructured":"Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nat Med. 1996;211:1174\u20138.","journal-title":"Nat Med"},{"key":"1152_CR9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659\u2013702.","journal-title":"Annu Rev Immunol"},{"key":"1152_CR10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fimmu.2016.00224","volume":"7","author":"R Bonecchi","year":"2016","unstructured":"Bonecchi R, Graham GJ. Atypical chemokine receptors and their roles in the resolution of the inflammatory response. Front Immunol. 2016;7:224.","journal-title":"Front Immunol"},{"key":"1152_CR11","first-page":"2218140","volume":"2022","author":"L Mu","year":"2022","unstructured":"Mu L, Hu S, Li G, et al. Characterization of the prognostic values of CXCL family in Epstein\u2013Barr virus associated gastric cancer. Oxid Med Cell Longev. 2022;2022:2218140.","journal-title":"Oxid Med Cell Longev"},{"key":"1152_CR12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4049\/jimmunol.150.3.1000","volume":"1503","author":"P Proost","year":"1993","unstructured":"Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol. 1993;1503:1000\u201310.","journal-title":"J Immunol"},{"key":"1152_CR13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"3387","author":"AD Luster","year":"1998","unstructured":"Luster AD. Chemokines\u2013chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;3387:436\u201345.","journal-title":"N Engl J Med"},{"key":"1152_CR14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2010.12.013","volume":"3021","author":"H Verbeke","year":"2011","unstructured":"Verbeke H, Struyf S, Berghmans N, et al. Isotypic neutralizing antibodies against mouse GCP-2\/CXCL6 inhibit melanoma growth and metastasis. Cancer Lett. 2011;3021:54\u201362.","journal-title":"Cancer Lett"},{"key":"1152_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cellsig.2018.11.004","volume":"54","author":"K Rajarathnam","year":"2019","unstructured":"Rajarathnam K, Schnoor M, Richardson RM, Rajagopal S. How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways. Cell Signal. 2019;54:69\u201380.","journal-title":"Cell Signal"},{"key":"1152_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13293-015-0047-5","volume":"6","author":"S Madalli","year":"2015","unstructured":"Madalli S, Beyrau M, Whiteford J, et al. Sex-specific regulation of chemokine Cxcl5\/6 controls neutrophil recruitment and tissue injury in acute inflammatory states. Biol Sex Differ. 2015;6:27.","journal-title":"Biol Sex Differ"},{"key":"1152_CR17","first-page":"911","volume":"5812","author":"MY Li","year":"2019","unstructured":"Li MY, Zhao Y, Luo YB, Li YH, Liu Y. The effect and mechanism of transient receptor potential M(2) in antigen-induced arthritis mice. Zhonghua Nei Ke Za Zhi. 2019;5812:911\u20134.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"19","key":"1152_CR18","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.3390\/ijms231911817","volume":"23","author":"J Chwastek","year":"2022","unstructured":"Chwastek J, K\u0119dziora M, Borczyk M, Korosty\u0144ski M, Starowicz K. Inflammation-driven secretion potential is upregulated in osteoarthritic fibroblast-like synoviocytes. Int J Mol Sci. 2022;23(19):11817.","journal-title":"Int J Mol Sci"},{"key":"1152_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13075-017-1472-0","volume":"191","author":"H Sato","year":"2017","unstructured":"Sato H, Muraoka S, Kusunoki N, et al. Resistin upregulates chemokine production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Res Ther. 2017;191:263.","journal-title":"Arthritis Res Ther"},{"key":"1152_CR20","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.3390\/molecules181114085","volume":"1811","author":"QY Choo","year":"2013","unstructured":"Choo QY, Ho PC, Tanaka Y, Lin HS. The histone deacetylase inhibitors MS-275 and SAHA suppress the p38 mitogen-activated protein kinase signaling pathway and chemotaxis in rheumatoid arthritic synovial fibroblastic E11 cells. Molecules. 2013;1811:14085\u201395.","journal-title":"Molecules"},{"key":"1152_CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13075-018-1638-4","volume":"201","author":"C Angiolilli","year":"2018","unstructured":"Angiolilli C, Kabala PA, Grabiec AM, et al. Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation. Arthritis Res Ther. 2018;201:148.","journal-title":"Arthritis Res Ther"},{"key":"1152_CR22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fphar.2019.00224","volume":"10","author":"MY Sun","year":"2019","unstructured":"Sun MY, Wang SJ, Li XQ, et al. CXCL6 promotes renal interstitial fibrosis in diabetic nephropathy by activating JAK\/STAT3 signaling pathway. Front Pharmacol. 2019;10:224.","journal-title":"Front Pharmacol"},{"key":"1152_CR23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.arcmed.2020.08.005","volume":"521","author":"SZ Wang","year":"2021","unstructured":"Wang SZ, Zhang YL, Shi HB. Potential repressive impact of microRNA-20a on renal tubular damage in diabetic kidney disease by targeting C-X-C motif chemokine ligand 6. Arch Med Res. 2021;521:58\u201368.","journal-title":"Arch Med Res"},{"key":"1152_CR24","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1096\/fj.201900351R","volume":"3310","author":"F Sallustio","year":"2019","unstructured":"Sallustio F, Stasi A, Curci C, et al. Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides. Faseb j. 2019;3310:10753\u201366.","journal-title":"Faseb j"},{"key":"1152_CR25","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1080\/21655979.2022.2030557","volume":"133","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Xi Y, Li Y, et al. Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1 (CXCL1) and C-X-C Motif Chemokine Ligand 6 (CXCL6) in models of early alcoholic liver disease. Bioengineered. 2022;133:4688\u2013701.","journal-title":"Bioengineered"},{"key":"1152_CR26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12864-015-1969-3","volume":"16","author":"AW Janssen","year":"2015","unstructured":"Janssen AW, Betzel B, Stoopen G, et al. The impact of PPAR\u03b1 activation on whole genome gene expression in human precision cut liver slices. BMC Genomics. 2015;16:760.","journal-title":"BMC Genomics"},{"key":"1152_CR27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1398-9995.2010.02444.x","volume":"661","author":"H Wang","year":"2011","unstructured":"Wang H, Chavali S, Mobini R, et al. A pathway-based approach to find novel markers of local glucocorticoid treatment in intermittent allergic rhinitis. Allergy. 2011;661:132\u201340.","journal-title":"Allergy"},{"key":"1152_CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cyto.2012.10.031","volume":"612","author":"L Bao","year":"2013","unstructured":"Bao L, Shi VY, Chan LS. IL-4 up-regulates epidermal chemotactic, angiogenic, and pro-inflammatory genes and down-regulates antimicrobial genes in vivo and in vitro: relevant in the pathogenesis of atopic dermatitis. Cytokine. 2013;612:419\u201325.","journal-title":"Cytokine"},{"key":"1152_CR29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","volume":"1674","author":"G Girolomoni","year":"2012","unstructured":"Girolomoni G, Mrowietz U, Paul C. Psoriasis: rationale for targeting interleukin-17. Br J Dermatol. 2012;1674:717\u201324.","journal-title":"Br J Dermatol"},{"key":"1152_CR30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00251-021-01224-7","volume":"736","author":"S Fang","year":"2021","unstructured":"Fang S, Xu X, Zhong L, et al. Bioinformatics-based study to identify immune infiltration and inflammatory-related hub genes as biomarkers for the treatment of rheumatoid arthritis. Immunogenetics. 2021;736:435\u201348.","journal-title":"Immunogenetics"},{"issue":"Suppl","key":"1152_CR31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF00915708","volume":"8","author":"G Weissmann","year":"1984","unstructured":"Weissmann G, Korchak H. Rheumatoid arthritis. The role of neutrophil activation. Inflammation. 1984;8(Suppl):S3-14.","journal-title":"Inflammation"},{"key":"1152_CR32","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.40066","volume":"696","author":"MK Demoruelle","year":"2017","unstructured":"Demoruelle MK, Harrall KK, Ho L, et al. Anti-citrullinated protein antibodies are associated with neutrophil extracellular traps in the sputum in relatives of rheumatoid arthritis patients. Arthritis Rheumatol. 2017;696:1165\u201375.","journal-title":"Arthritis Rheumatol"},{"key":"1152_CR33","first-page":"8549329","volume":"2018","author":"W Chen","year":"2018","unstructured":"Chen W, Wang Q, Ke Y, Lin J. Neutrophil function in an inflammatory milieu of rheumatoid arthritis. J Immunol Res. 2018;2018:8549329.","journal-title":"J Immunol Res"},{"issue":"1","key":"1152_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/cells9010043","volume":"9","author":"D Appelgren","year":"2019","unstructured":"Appelgren D, Enocsson H, Skogman BH, et al. Neutrophil extracellular traps (NETs) in the cerebrospinal fluid samples from children and adults with central nervous system Infections. Cells. 2019;9(1):43.","journal-title":"Cells"},{"key":"1152_CR35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/mi.2015.43","volume":"91","author":"S Jovic","year":"2016","unstructured":"Jovic S, Linge HM, Shikhagaie MM, et al. The neutrophil-recruiting chemokine GCP-2\/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA. Mucosal Immunol. 2016;91:112\u201323.","journal-title":"Mucosal Immunol"},{"key":"1152_CR36","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1128\/AAC.00028-08","volume":"527","author":"HM Linge","year":"2008","unstructured":"Linge HM, Collin M, Nordenfelt P, M\u00f6rgelin M, Malmsten M, Egesten A. The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)\/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob Agents Chemother. 2008;527:2599\u2013607.","journal-title":"Antimicrob Agents Chemother"},{"key":"1152_CR37","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1093\/jn\/nxab313","volume":"15112","author":"E Hulander","year":"2021","unstructured":"Hulander E, B\u00e4rebring L, Turesson Wadell A, et al. Proposed anti-inflammatory diet reduces inflammation in compliant, weight-stable patients with rheumatoid arthritis in a randomized controlled crossover trial. J Nutr. 2021;15112:3856\u201364.","journal-title":"J Nutr"},{"key":"1152_CR38","doi-asserted-by":"crossref","first-page":"509259","DOI":"10.1155\/2013\/509259","volume":"2013","author":"H Petra","year":"2013","unstructured":"Petra H, Eva H, Irena B, Petra H, Ond\u0159ej V. Molecular profiling of acute and chronic rejections of renal allografts. Clin Dev Immunol. 2013;2013:509259.","journal-title":"Clin Dev Immunol"},{"key":"1152_CR39","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3389\/fphar.2019.01596","volume":"10","author":"YL Shen","year":"2019","unstructured":"Shen YL, Jiang YP, Li XQ, et al. ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6\/JAK\/STAT3 signaling pathway. Front Pharmacol. 2019;10:1596.","journal-title":"Front Pharmacol"},{"key":"1152_CR40","doi-asserted-by":"crossref","first-page":"5513690","DOI":"10.1155\/2021\/5513690","volume":"2021","author":"L Krupickova","year":"2021","unstructured":"Krupickova L, Fialova M, Novotny M, et al. Chemokine profiles are affected in serum of patients with acute rejection of kidney allograft. Mediators Inflamm. 2021;2021:5513690.","journal-title":"Mediators Inflamm"},{"key":"1152_CR41","doi-asserted-by":"crossref","first-page":"16447","DOI":"10.1002\/jcp.28313","volume":"234","author":"M Zeng","year":"2019","unstructured":"Zeng M, Liu J, Yang W, et al. Multiple-microarray analysis for identification of hub genes involved in tubulointerstial injury in diabetic nephropathy. J Cell Physiol. 2019;234:16447\u201362.","journal-title":"J Cell Physiol"},{"key":"1152_CR42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/bmm-2018-0339","volume":"133","author":"X Wang","year":"2019","unstructured":"Wang X, Li J, Wang Z, Deng A. Wound exudate CXCL6: a potential biomarker for wound healing of diabetic foot ulcers. Biomark Med. 2019;133:167\u201374.","journal-title":"Biomark Med"},{"key":"1152_CR43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S2468-1253(19)30326-7","volume":"55","author":"TS Sehrawat","year":"2020","unstructured":"Sehrawat TS, Liu M, Shah VH. The knowns and unknowns of treatment for alcoholic hepatitis. Lancet Gastroenterol Hepatol. 2020;55:494\u2013506.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1152_CR44","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-021-24843-w","volume":"121","author":"M Liu","year":"2021","unstructured":"Liu M, Cao S, He L, et al. Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis. Nat Commun. 2021;121:4560.","journal-title":"Nat Commun"},{"key":"1152_CR45","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"1365","author":"M Dominguez","year":"2009","unstructured":"Dominguez M, Miquel R, Colmenero J, et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;1365:1639\u201350.","journal-title":"Gastroenterology"},{"key":"1152_CR46","doi-asserted-by":"crossref","first-page":"110286","DOI":"10.1016\/j.biopha.2020.110286","volume":"128","author":"M Chen","year":"2020","unstructured":"Chen M, Xing J, Pan D, Peng X, Gao P. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-\u03baB pathway. Biomed Pharmacother. 2020;128:110286.","journal-title":"Biomed Pharmacother"},{"key":"1152_CR47","first-page":"479","volume":"213","author":"MY Xu","year":"2016","unstructured":"Xu MY, Qu Y, Li Z, Li F, Xiao CY, Lu LG. A 6 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis B. Front Biosci (Landmark Ed). 2016;213:479\u201386.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1152_CR48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/lt.26031","volume":"276","author":"A Aregay","year":"2021","unstructured":"Aregay A, Engel B, Port K, et al. Distinct immune imprints of post-liver transplantation hepatitis C persist despite viral clearance. Liver Transpl. 2021;276:887\u201399.","journal-title":"Liver Transpl"},{"key":"1152_CR49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2249.2005.02773.x","volume":"1402","author":"F Sachse","year":"2005","unstructured":"Sachse F, Ahlers F, Stoll W, Rudack C. Neutrophil chemokines in epithelial inflammatory processes of human tonsils. Clin Exp Immunol. 2005;1402:293\u2013300.","journal-title":"Clin Exp Immunol"},{"key":"1152_CR50","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00705-020-04730-3","volume":"16510","author":"Y Jang","year":"2020","unstructured":"Jang Y, Seo SH. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2. Arch Virol. 2020;16510:2205\u201311.","journal-title":"Arch Virol"},{"key":"1152_CR51","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1074\/mcp.RA119.001546","volume":"195","author":"O Touzelet","year":"2020","unstructured":"Touzelet O, Broadbent L, Armstrong SD, et al. The secretome profiling of a pediatric airway epithelium infected with hRSV identified aberrant apical\/basolateral trafficking and novel immune modulating (CXCL6, CXCL16, CSF3) and antiviral (CEACAM1) proteins. Mol Cell Proteomics. 2020;195:793\u2013807.","journal-title":"Mol Cell Proteomics"},{"key":"1152_CR52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2016.08.019","volume":"5931","author":"H Moazzeni","year":"2016","unstructured":"Moazzeni H, Akbari MT, Yazdani S, Elahi E. Expression of CXCL6 and BBS5 that may be glaucoma relevant genes is regulated by PITX2. Gene. 2016;5931:76\u201383.","journal-title":"Gene"},{"key":"1152_CR53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10565-016-9322-4","volume":"323","author":"C Chen","year":"2016","unstructured":"Chen C, Shi L, Li Y, Wang X, Yang S. Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. Cell Biol Toxicol. 2016;323:169\u201384.","journal-title":"Cell Biol Toxicol"},{"key":"1152_CR54","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1158\/0008-5472.CAN-09-2099","volume":"6920","author":"L Xu","year":"2009","unstructured":"Xu L, Duda DG, di Tomaso E, et al. Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer Res. 2009;6920:7905\u201310.","journal-title":"Cancer Res"},{"key":"1152_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrac072","author":"K Holmgren","year":"2022","unstructured":"Holmgren K, Jonsson P, Lundin C, et al. Preoperative biomarkers related to inflammation may identify high-risk anastomoses in colorectal cancer surgery: explorative study. BJS Open. 2022. https:\/\/doi.org\/10.1093\/bjsopen\/zrac072.","journal-title":"BJS Open."},{"key":"1152_CR56","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/eji.200324807","volume":"347","author":"K Gijsbers","year":"2004","unstructured":"Gijsbers K, Van Assche G, Joossens S, et al. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8\/CXCL8 production by leukocytes in Crohn\u2019s disease and selective GCP-2\/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol. 2004;347:1992\u20132000.","journal-title":"Eur J Immunol"},{"key":"1152_CR57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/JIR.S203714","volume":"12","author":"MA Boshagh","year":"2019","unstructured":"Boshagh MA, Foroutan P, Moloudi MR, et al. ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis. J Inflamm Res. 2019;12:167\u201374.","journal-title":"J Inflamm Res"},{"key":"1152_CR58","first-page":"1916","volume":"7","author":"SF Khaiboullina","year":"2016","unstructured":"Khaiboullina SF, Abdulkhakov S, Khalikova A, et al. Serum cytokine signature that discriminates helicobacter pylori positive and negative juvenile gastroduodenitis. Front Microbiol. 2016;7:1916.","journal-title":"Front Microbiol"},{"key":"1152_CR59","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.crohns.2014.02.009","volume":"810","author":"Z Kerami","year":"2014","unstructured":"Kerami Z, Duijvis NW, Vogels EW, van Dooren FH, Moerland PD, Te Velde AA. Effect of interleukin-17 on gene expression profile of fibroblasts from Crohn\u2019s disease patients. J Crohns Colitis. 2014;810:1208\u201316.","journal-title":"J Crohns Colitis"},{"key":"1152_CR60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1751-2980.2008.00336.x","volume":"93","author":"MA Alzoghaibi","year":"2008","unstructured":"Alzoghaibi MA, Al-Mofleh IA, Al-Jebreen AM. Neutrophil chemokines GCP-2 and GRO-alpha in patients with inflammatory bowel disease. J Dig Dis. 2008;93:144\u20138.","journal-title":"J Dig Dis"},{"issue":"Suppl","key":"1152_CR61","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ajog.2015.08.040","volume":"2134","author":"CJ Kim","year":"2015","unstructured":"Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol. 2015;2134(Suppl):S29-52.","journal-title":"Am J Obstet Gynecol"},{"key":"1152_CR62","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0897.2008.00620.x","volume":"603","author":"P Mittal","year":"2008","unstructured":"Mittal P, Romero R, Kusanovic JP, et al. CXCL6 (granulocyte chemotactic protein-2): a novel chemokine involved in the innate immune response of the amniotic cavity. Am J Reprod Immunol. 2008;603:246\u201357.","journal-title":"Am J Reprod Immunol"},{"key":"1152_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22203\/eCM.v031a01","volume":"31","author":"S Grad","year":"2016","unstructured":"Grad S, Bow C, Karppinen J, et al. Systemic blood plasma CCL5 and CXCL6: potential biomarkers for human lumbar disc degeneration. Eur Cell Mater. 2016;31:1\u201310.","journal-title":"Eur Cell Mater"},{"key":"1152_CR64","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.2174\/0929867327666200824112732","volume":"2815","author":"G Plemmenos","year":"2021","unstructured":"Plemmenos G, Evangeliou E, Polizogopoulos N, Chalazias A, Deligianni M, Piperi C. Central regulatory role of cytokines in periodontitis and targeting options. Curr Med Chem. 2021;2815:3032\u201358.","journal-title":"Curr Med Chem"},{"key":"1152_CR65","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-0765.2008.01134.x","volume":"444","author":"M Kebschull","year":"2009","unstructured":"Kebschull M, Demmer R, Behle JH, et al. Granulocyte chemotactic protein 2 (gcp-2\/cxcl6) complements interleukin-8 in periodontal disease. J Periodontal Res. 2009;444:465\u201371.","journal-title":"J Periodontal Res"},{"key":"1152_CR66","first-page":"191","volume":"262","author":"\u00c7 Y\u00fccel","year":"2020","unstructured":"Y\u00fccel \u00c7, F\u0131rat O\u011fuz E, Er S, Balamir \u0130, Turhan T, Tez M. Diagnostic value of GCP-2\/CXCL-6 and hs-CRP in the diagnosis of acute appendicitis. Ulus Travma Acil Cerrahi Derg. 2020;262:191\u20136.","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"1152_CR67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jdermsci.2013.01.007","volume":"701","author":"M Hasegawa","year":"2013","unstructured":"Hasegawa M, Higashi K, Matsushita T, et al. Dermokine inhibits ELR(+)CXC chemokine expression and delays early skin wound healing. J Dermatol Sci. 2013;701:34\u201341.","journal-title":"J Dermatol Sci"},{"key":"1152_CR68","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/156652408785160998","volume":"85","author":"SL Traves","year":"2008","unstructured":"Traves SL, Donnelly LE. Th17 cells in airway diseases. Curr Mol Med. 2008;85:416\u201326.","journal-title":"Curr Mol Med"},{"key":"1152_CR69","doi-asserted-by":"crossref","first-page":"154873","DOI":"10.1016\/j.cyto.2019.154873","volume":"126","author":"C Saini","year":"2020","unstructured":"Saini C, Srivastava RK, Kumar P, Ramesh V, Sharma A. A distinct double positive IL-17A(+)\/F(+) T helper 17 cells induced inflammation leads to IL17 producing neutrophils in Type 1 reaction of leprosy patients. Cytokine. 2020;126:154873.","journal-title":"Cytokine"},{"key":"1152_CR70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cyto.2014.07.006","volume":"702","author":"L Vistejnova","year":"2014","unstructured":"Vistejnova L, Safrankova B, Nesporova K, et al. Low molecular weight hyaluronan mediated CD44 dependent induction of IL-6 and chemokines in human dermal fibroblasts potentiates innate immune response. Cytokine. 2014;702:97\u2013103.","journal-title":"Cytokine"},{"key":"1152_CR71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cyto.2008.05.012","volume":"432","author":"LA Begley","year":"2008","unstructured":"Begley LA, Kasina S, MacDonald J, Macoska JA. The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine. 2008;432:194\u20139.","journal-title":"Cytokine"},{"key":"1152_CR72","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12906-020-02943-2","volume":"201","author":"Y Dong","year":"2020","unstructured":"Dong Y, Liu J, Xue Z, et al. Pao Pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NF\u03baB signaling. BMC Complement Med Ther. 2020;201:150.","journal-title":"BMC Complement Med Ther"},{"key":"1152_CR73","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/pros.22953","volume":"757","author":"S Bernichtein","year":"2015","unstructured":"Bernichtein S, Pigat N, Camparo P, et al. Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon\u00ae) in a mouse model of prostate hyperplasia. Prostate. 2015;757:706\u201322.","journal-title":"Prostate"},{"key":"1152_CR74","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000502213","volume":"326","author":"L Huth","year":"2019","unstructured":"Huth L, Marquardt Y, Heise R, et al. Bifonazole exerts anti-inflammatory effects in human three-dimensional skin equivalents after UVB or histamine challenge. Skin Pharmacol Physiol. 2019;326:337\u201343.","journal-title":"Skin Pharmacol Physiol"},{"key":"1152_CR75","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.trecan.2018.10.002","volume":"412","author":"L Laplane","year":"2018","unstructured":"Laplane L, Duluc D, Larmonier N, Pradeu T, Bikfalvi A. The multiple layers of the tumor environment. Trends Cancer. 2018;412:802\u20139.","journal-title":"Trends Cancer"},{"key":"1152_CR76","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.31792","volume":"735","author":"M Song","year":"2021","unstructured":"Song M, He J, Pan QZ, et al. Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression. Hepatology. 2021;735:1717\u201335.","journal-title":"Hepatology"},{"key":"1152_CR77","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1002\/jcp.30236","volume":"2367","author":"S Zheng","year":"2021","unstructured":"Zheng S, Shen T, Liu Q, et al. CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway. J Cell Physiol. 2021;2367:5373\u201386.","journal-title":"J Cell Physiol"},{"key":"1152_CR78","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.biopha.2017.11.004","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, Tang Z, Wang H, et al. CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p. Biomed Pharmacother. 2018;97:1182\u20138.","journal-title":"Biomed Pharmacother"},{"key":"1152_CR79","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1535370220960675","volume":"2461","author":"L Li","year":"2021","unstructured":"Li L, Man J, Zhao L. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia. Exp Biol Med. 2021;2461:84\u201396.","journal-title":"Exp Biol Med"},{"key":"1152_CR80","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.20130783","volume":"21010","author":"A Iannello","year":"2013","unstructured":"Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J Exp Med. 2013;21010:2057\u201369.","journal-title":"J Exp Med"},{"key":"1152_CR81","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/carcin\/bgr270","volume":"332","author":"WA Yeudall","year":"2012","unstructured":"Yeudall WA, Vaughan CA, Miyazaki H, et al. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration. Carcinogenesis. 2012;332:442\u201351.","journal-title":"Carcinogenesis"},{"key":"1152_CR82","doi-asserted-by":"crossref","first-page":"18691","DOI":"10.1073\/pnas.1412062112","volume":"11152","author":"R Otomo","year":"2014","unstructured":"Otomo R, Otsubo C, Matsushima-Hibiya Y, et al. TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion. Proc Natl Acad Sci U S A. 2014;11152:18691\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1152_CR83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12935-021-01806-1","volume":"211","author":"J Wan","year":"2021","unstructured":"Wan J, Liu S, Sun W, et al. Ring finger protein 152-dependent degradation of TSPAN12 suppresses hepatocellular carcinoma progression. Cancer Cell Int. 2021;211:122.","journal-title":"Cancer Cell Int"},{"key":"1152_CR84","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fphar.2019.00307","volume":"10","author":"G Liu","year":"2019","unstructured":"Liu G, An L, Zhang H, Du P, Sheng Y. Activation of CXCL6\/CXCR1\/2 axis promotes the growth and metastasis of osteosarcoma cells in vitro and in vivo. Front Pharmacol. 2019;10:307.","journal-title":"Front Pharmacol"},{"key":"1152_CR85","doi-asserted-by":"crossref","first-page":"L496","DOI":"10.1152\/ajplung.00290.2015","volume":"3106","author":"N Tiwari","year":"2016","unstructured":"Tiwari N, Marudamuthu AS, Tsukasaki Y, Ikebe M, Fu J, Shetty S. p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure. Am J Physiol Lung Cell Mol Physiol. 2016;3106:L496-506.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1152_CR86","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1158\/0008-5472.CAN-12-1097","volume":"7222","author":"S Vicent","year":"2012","unstructured":"Vicent S, Sayles LC, Vaka D, et al. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res. 2012;7222:5744\u201356.","journal-title":"Cancer Res"},{"key":"1152_CR87","first-page":"1631","volume":"735","author":"MML Lei","year":"2021","unstructured":"Lei MML, Lee TKW. Cancer-associated fibroblasts: orchestrating the crosstalk between liver cancer cells and neutrophils through the cardiotrophin-like cytokine factor 1-mediated chemokine (C-X-C motif) ligand 6\/TGF-\u03b2 axis. Hepatology. 2021;735:1631\u20133.","journal-title":"Hepatology"},{"key":"1152_CR88","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.4049\/jimmunol.175.9.6177","volume":"1759","author":"M Numasaki","year":"2005","unstructured":"Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;1759:6177\u201389.","journal-title":"J Immunol"},{"key":"1152_CR89","first-page":"120","volume":"201","author":"M Zhang","year":"2015","unstructured":"Zhang M, Wang G, Tao Y, Zhang H. The proinflammatory effect and molecular mechanism of IL- 17 in the intestinal epithelial cell line HT-29. J buon. 2015;201:120\u20137.","journal-title":"J buon"},{"key":"1152_CR90","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1002\/ctm2.484","volume":"116","author":"ZG Shan","year":"2021","unstructured":"Shan ZG, Chen J, Liu JS, et al. Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-\u03b1-B7-H2-dependent pathway in human gastric cancer. Clin Transl Med. 2021;116:e484.","journal-title":"Clin Transl Med"},{"key":"1152_CR91","doi-asserted-by":"crossref","first-page":"1025820","DOI":"10.1155\/2017\/1025820","volume":"2017","author":"KN Sivanathan","year":"2017","unstructured":"Sivanathan KN, Rojas-Canales D, Grey ST, Gronthos S, Coates PT. Transcriptome profiling of IL-17A preactivated mesenchymal stem cells: a comparative study to unmodified and IFN-\u03b3 modified mesenchymal stem cells. Stem Cells Int. 2017;2017:1025820.","journal-title":"Stem Cells Int"},{"key":"1152_CR92","first-page":"1065","volume":"202","author":"L Liu","year":"2019","unstructured":"Liu L, Sun H, Wu S, et al. IL-17A promotes CXCR2-dependent angiogenesis in a mouse model of liver cancer. Mol Med Rep. 2019;202:1065\u201374.","journal-title":"Mol Med Rep"},{"key":"1152_CR93","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/sj.bjc.6603177","volume":"9412","author":"YM Zhu","year":"2006","unstructured":"Zhu YM, Bagstaff SM, Woll PJ. Production and upregulation of granulocyte chemotactic protein-2\/CXCL6 by IL-1beta and hypoxia in small cell lung cancer. Br J Cancer. 2006;9412:1936\u201341.","journal-title":"Br J Cancer"},{"key":"1152_CR94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.imlet.2010.08.002","volume":"1332","author":"E Ferretti","year":"2010","unstructured":"Ferretti E, Di Carlo E, Cocco C, et al. Direct inhibition of human acute myeloid leukemia cell growth by IL-12. Immunol Lett. 2010;1332:99\u2013105.","journal-title":"Immunol Lett"},{"key":"1152_CR95","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20070406","volume":"2048","author":"YH Wang","year":"2007","unstructured":"Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med. 2007;2048:1837\u201347.","journal-title":"J Exp Med"},{"key":"1152_CR96","doi-asserted-by":"crossref","first-page":"e1397249","DOI":"10.1080\/2162402X.2017.1397249","volume":"73","author":"E Ferretti","year":"2018","unstructured":"Ferretti E, Di Carlo E, Ognio E, et al. IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis. Oncoimmunology. 2018;73:e1397249.","journal-title":"Oncoimmunology"},{"key":"1152_CR97","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.1014241108","volume":"1084","author":"CJ Corrigan","year":"2011","unstructured":"Corrigan CJ, Wang W, Meng Q, et al. T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci U S A. 2011;1084:1579\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1152_CR98","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1365-2222.2012.04062.x","volume":"4211","author":"W Wang","year":"2012","unstructured":"Wang W, Fan YQ, Lv Z, et al. Interleukin-25 promotes basic fibroblast growth factor expression by human endothelial cells through interaction with IL-17RB, but not IL-17RA. Clin Exp Allergy. 2012;4211:1604\u201314.","journal-title":"Clin Exp Allergy"},{"key":"1152_CR99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cncr.25563","volume":"1171","author":"Y Li","year":"2011","unstructured":"Li Y, Flores R, Yu A, et al. Elevated expression of CXC chemokines in pediatric osteosarcoma patients. Cancer. 2011;1171:207\u201317.","journal-title":"Cancer"},{"key":"1152_CR100","doi-asserted-by":"crossref","first-page":"e89991","DOI":"10.1371\/journal.pone.0089991","volume":"92","author":"N Wang","year":"2014","unstructured":"Wang N, Feng Y, Wang Q, et al. Neutrophils infiltration in the tongue squamous cell carcinoma and its correlation with CEACAM1 expression on tumor cells. PLoS ONE. 2014;92:e89991.","journal-title":"PLoS ONE"},{"issue":"2","key":"1152_CR101","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ijms22020843","volume":"22","author":"J Korbecki","year":"2021","unstructured":"Korbecki J, Kojder K, Kapczuk P, et al. The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors\u2014a review of literature. Int J Mol Sci. 2021;22(2):843.","journal-title":"Int J Mol Sci"},{"key":"1152_CR102","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/OTT.S184235","volume":"12","author":"Q Chen","year":"2019","unstructured":"Chen Q, Liu D, Hu Z, Luo C, Zheng SL. miRNA-101-5p inhibits the growth and aggressiveness of NSCLC cells through targeting CXCL6. Onco Targets Ther. 2019;12:835\u201348.","journal-title":"Onco Targets Ther"},{"key":"1152_CR103","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1002\/jcb.29672","volume":"12111","author":"M Zhao","year":"2020","unstructured":"Zhao M, Dong G, Meng Q, Lin S, Li X. Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells. J Cell Biochem. 2020;12111:4440\u20139.","journal-title":"J Cell Biochem"},{"key":"1152_CR104","first-page":"1957","volume":"235","author":"W Shen","year":"2019","unstructured":"Shen W, Xie XY, Liu MR, Wang LL. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6. Eur Rev Med Pharmacol Sci. 2019;235:1957\u201368.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1152_CR105","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.2147\/OTT.S256238","volume":"13","author":"C Sun","year":"2020","unstructured":"Sun C, Li G, Liu M. A novel circular RNA, circ_0005394, predicts unfavorable prognosis and contributes to hepatocellular carcinoma progression by regulating miR-507\/E2F3 and miR-515-5p\/CXCL6 signaling pathways. Onco Targets Ther. 2020;13:6171\u201380.","journal-title":"Onco Targets Ther"},{"key":"1152_CR106","doi-asserted-by":"crossref","first-page":"215737","DOI":"10.1016\/j.canlet.2022.215737","volume":"540","author":"N Walterskirchen","year":"2022","unstructured":"Walterskirchen N, M\u00fcller C, Ramos C, et al. Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression. Cancer Lett. 2022;540:215737.","journal-title":"Cancer Lett"},{"key":"1152_CR107","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fmed.2020.00264","volume":"7","author":"S Guil-Luna","year":"2020","unstructured":"Guil-Luna S, Mena R, Navarrete-Sirvent C, et al. Association of tumor budding with immune evasion pathways in primary colorectal cancer and patient-derived xenografts. Front Med. 2020;7:264.","journal-title":"Front Med"},{"key":"1152_CR108","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1159\/000366357","volume":"345","author":"H Tian","year":"2014","unstructured":"Tian H, Huang P, Zhao Z, Tang W, Xia J. HIF-1\u03b1 plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression. Cell Physiol Biochem. 2014;345:1536\u201346.","journal-title":"Cell Physiol Biochem"},{"key":"1152_CR109","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","volume":"6810","author":"TT Onder","year":"2008","unstructured":"Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;6810:3645\u201354.","journal-title":"Cancer Res"},{"key":"1152_CR110","first-page":"5167","volume":"2328","author":"JC Ma","year":"2017","unstructured":"Ma JC, Sun XW, Su H, et al. Fibroblast-derived CXCL12\/SDF-1\u03b1 promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K\/Akt\/mTOR pathway in colon cancer. World J Gastroenterol. 2017;2328:5167\u201378.","journal-title":"World J Gastroenterol"},{"key":"1152_CR111","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1080\/21655979.2021.1987820","volume":"121","author":"C Zhang","year":"2021","unstructured":"Zhang C, Tang B, Hu J, et al. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer. Bioengineered. 2021;121:8872\u201384.","journal-title":"Bioengineered"},{"key":"1152_CR112","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.tcb.2022.04.007","volume":"32","author":"FS Rodrigues","year":"2022","unstructured":"Rodrigues FS, Ciccarelli FD, Malanchi I. Reflected stemness as a potential driver of the tumour microenvironment. Trends Cell Biol. 2022;32:979\u201387.","journal-title":"Trends Cell Biol"},{"key":"1152_CR113","first-page":"3558200","volume":"2022","author":"J Bian","year":"2022","unstructured":"Bian J, Fu J, Wang X, et al. Characterization of immunogenicity of malignant cells with stemness in intrahepatic cholangiocarcinoma by single-cell RNA sequencing. Stem Cells Int. 2022;2022:3558200.","journal-title":"Stem Cells Int"},{"key":"1152_CR114","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yexcr.2004.09.027","volume":"3032","author":"K Gijsbers","year":"2005","unstructured":"Gijsbers K, Gouwy M, Struyf S, et al. GCP-2\/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp Cell Res. 2005;3032:331\u201342.","journal-title":"Exp Cell Res"},{"key":"1152_CR115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pros.22747","volume":"743","author":"GS Karagiannis","year":"2014","unstructured":"Karagiannis GS, Saraon P, Jarvi KA, Diamandis EP. Proteomic signatures of angiogenesis in androgen-independent prostate cancer. Prostate. 2014;743:260\u201372.","journal-title":"Prostate"},{"key":"1152_CR116","first-page":"19","volume":"201","author":"M Mohammadi Najafabadi","year":"2018","unstructured":"Mohammadi Najafabadi M, Shamsasenjan K, Akbarzadehlaleh P. The angiogenic chemokines expression profile of myeloid cell lines co-cultured with bone marrow-derived mesenchymal stem cells. Cell J. 2018;201:19\u201324.","journal-title":"Cell J"},{"key":"1152_CR117","doi-asserted-by":"crossref","first-page":"14280","DOI":"10.1073\/pnas.1009559107","volume":"10732","author":"AE Burrows","year":"2010","unstructured":"Burrows AE, Smogorzewska A, Elledge SJ. Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc Natl Acad Sci U S A. 2010;10732:14280\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1152_CR118","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10456-017-9576-3","volume":"204","author":"JR van Beijnum","year":"2017","unstructured":"van Beijnum JR, Nowak-Sliwinska P, van Berkel M, Wong TJ, Griffioen AW. A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7). Angiogenesis. 2017;204:641\u201354.","journal-title":"Angiogenesis"},{"key":"1152_CR119","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/rheumatology\/kev399","volume":"554","author":"PS Tsou","year":"2016","unstructured":"Tsou PS, Rabquer BJ, Ohara RA, et al. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines. Rheumatology. 2016;554:745\u201354.","journal-title":"Rheumatology"},{"key":"1152_CR120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biopha.2010.09.006","volume":"6410","author":"ZY Lin","year":"2010","unstructured":"Lin ZY, Chuang WL. Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Biomed Pharmacother. 2010;6410:659\u201362.","journal-title":"Biomed Pharmacother"},{"key":"1152_CR121","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-079X.2009.00742.x","volume":"482","author":"SY Park","year":"2010","unstructured":"Park SY, Jang WJ, Yi EY, et al. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res. 2010;482:178\u201384.","journal-title":"J Pineal Res"},{"key":"1152_CR122","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1038\/s41598-020-61622-x","volume":"101","author":"A Gonz\u00e1lez-Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez A, Gonz\u00e1lez A, Rueda N, et al. Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process. Sci Rep. 2020;101:4790.","journal-title":"Sci Rep"},{"key":"1152_CR123","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphys.2019.00879","volume":"10","author":"A Gonz\u00e1lez-Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez A, Gonz\u00e1lez A, Rueda N, et al. Melatonin enhances the usefulness of ionizing radiation: involving the regulation of different steps of the angiogenic process. Front Physiol. 2019;10:879.","journal-title":"Front Physiol"},{"key":"1152_CR124","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/15384047.2020.1842705","volume":"221","author":"X Wang","year":"2021","unstructured":"Wang X, Dai Y, Zhang X, et al. CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia-reperfusion injury by modulating Sirt3 expression via AKT\/FOXO3a activation. Cancer Biol Ther. 2021;221:30\u20139.","journal-title":"Cancer Biol Ther"},{"key":"1152_CR125","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1053\/j.gastro.2005.09.010","volume":"1296","author":"T Asselah","year":"2005","unstructured":"Asselah T, Bi\u00e8che I, Laurendeau I, et al. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology. 2005;1296:2064\u201375.","journal-title":"Gastroenterology"},{"key":"1152_CR126","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1189\/jlb.0313140","volume":"946","author":"AG Besnard","year":"2013","unstructured":"Besnard AG, Struyf S, Guabiraba R, et al. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model. J Leukoc Biol. 2013;946:1317\u201323.","journal-title":"J Leukoc Biol"},{"key":"1152_CR127","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3899\/jrheum.161092","volume":"448","author":"T Taniguchi","year":"2017","unstructured":"Taniguchi T, Asano Y, Nakamura K, et al. Fli1 Deficiency induces CXCL6 expression in dermal fibroblasts and endothelial cells, contributing to the development of fibrosis and vasculopathy in systemic sclerosis. J Rheumatol. 2017;448:1198\u2013205.","journal-title":"J Rheumatol"},{"key":"1152_CR128","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1111\/jcmm.13787","volume":"2210","author":"X Cai","year":"2018","unstructured":"Cai X, Li Z, Zhang Q, et al. CXCL6-EGFR-induced Kupffer cells secrete TGF-\u03b21 promoting hepatic stellate cell activation via the SMAD2\/BRD4\/C-MYC\/EZH2 pathway in liver fibrosis. J Cell Mol Med. 2018;2210:5050\u201361.","journal-title":"J Cell Mol Med"},{"key":"1152_CR129","doi-asserted-by":"crossref","first-page":"683506","DOI":"10.3389\/fmed.2021.683506","volume":"8","author":"C Wu","year":"2021","unstructured":"Wu C, Cheng D, Peng Y, et al. Hepatic BRD4 Is upregulated in liver fibrosis of various etiologies and positively correlated to fibrotic severity. Front Med. 2021;8:683506.","journal-title":"Front Med"},{"key":"1152_CR130","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1136\/annrheumdis-2014-205546","volume":"7412","author":"J Sherwood","year":"2015","unstructured":"Sherwood J, Bertrand J, Nalesso G, et al. A homeostatic function of CXCR2 signalling in articular cartilage. Ann Rheum Dis. 2015;7412:2207\u201315.","journal-title":"Ann Rheum Dis"},{"key":"1152_CR131","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s13287-021-02481-9","volume":"121","author":"K Kawata","year":"2021","unstructured":"Kawata K, Koga H, Tsuji K, et al. Extracellular vesicles derived from mesenchymal stromal cells mediate endogenous cell growth and migration via the CXCL5 and CXCL6\/CXCR2 axes and repair menisci. Stem Cell Res Ther. 2021;121:414.","journal-title":"Stem Cell Res Ther"},{"key":"1152_CR132","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/cvr\/cvy086","volume":"11410","author":"Y Min","year":"2018","unstructured":"Min Y, Han S, Aae Ryu H, Kim SW. Human adipose mesenchymal stem cells overexpressing dual chemotactic gene showed enhanced angiogenic capacity in ischaemic hindlimb model. Cardiovasc Res. 2018;11410:1400\u20139.","journal-title":"Cardiovasc Res"},{"key":"1152_CR133","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvs224","volume":"954","author":"SW Kim","year":"2012","unstructured":"Kim SW, Lee DW, Yu LH, et al. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model. Cardiovasc Res. 2012;954:495\u2013506.","journal-title":"Cardiovasc Res"},{"key":"1152_CR134","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"545","author":"AJ Ozga","year":"2021","unstructured":"Ozga AJ, Chow MT, Luster AD. Chemokines and the immune response to cancer. Immunity. 2021;545:859\u201374.","journal-title":"Immunity"},{"key":"1152_CR135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-21-0369","volume":"121","author":"KH Tang","year":"2022","unstructured":"Tang KH, Li S, Khodadadi-Jamayran A, et al. Combined inhibition of SHP2 and CXCR1\/2 promotes antitumor T-cell response in NSCLC. Cancer Discov. 2022;121:47\u201361.","journal-title":"Cancer Discov"},{"key":"1152_CR136","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","volume":"1919","author":"SI Rennard","year":"2015","unstructured":"Rennard SI, Dale DC, Donohue JF, et al. CXCR2 antagonist MK-7123 A phase 2 proof-of-concept trial for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;1919:1001\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"1152_CR137","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","volume":"410","author":"PM O'Byrne","year":"2016","unstructured":"O\u2019Byrne PM, Metev H, Puu M, et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2016;410:797\u2013806.","journal-title":"Lancet Respir Med"}],"updated-by":[{"DOI":"10.1007\/s10238-023-01209-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000}}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01152-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:11:14Z","timestamp":1702725074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01152-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":137,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01152-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10238-023-01209-8","URL":"https:\/\/doi.org\/10.1007\/s10238-023-01209-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The review was written in accordance with ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors gave consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}